← Leaderboards
Diane V Havlir
University Of California, San Francisco
$125,216,731
Attributed
$152,621,071
Total exposure
23
Grants
20
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $22.1M · FY2005–25$25M$18.8M$12.5M$6.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$175,182,850 · 24
By mechanism
U01$85,063,920 · 6
P01$35,142,208 · 9
UM1$33,898,807 · 2
T32$5,983,787 · 1
UH3$5,742,657 · 1
R01$3,863,551 · 1
Top collaborators
- Susan Buchbinder15 shared
- Moses Robert Kamya5 shared
- Maya Liv Petersen5 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Michelle Roh$1,088,445
- Zvavahera Mike Chirenje$118,149,266
- Craig R Cohen$97,239,582
- Urvi M. Parikh$1,674,974
- Anke Hemmerling$766,589
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseAfricaPreventUgandaProgramsHiv InfectionsCommunitiesNovel StrategiesMalariaEnrollmentClinical TrialsAreaRandomizedPreventionAfrica South Of The SaharaStandard Of CareAffectLifeTransmission ProcessTrainingAntiretroviral TherapyPregnant WomenResearch PersonnelChild
Grant awards (134)
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa$4,683,868
U01 · FY2025 · AI · contact PI
San Francisco Bay Clinical Trials Unit (CTU)$1,477,862
UM1 · FY2025 · AI
San Francisco Bay Clinical Trials Unit (CTU)$1,093,620
UM1 · FY2025 · AI
Training in HIV Translational Research$476,663
T32 · FY2025 · AI · contact PI
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa$4,681,367
U01 · FY2024 · AI · contact PI
San Francisco Bay Clinical Trials Unit (CTU)$1,415,883
UM1 · FY2024 · AI
Training in HIV Translational Research$453,828
T32 · FY2024 · AI · contact PI
San Francisco Bay Clinical Trials Unit (CTU)$52,356
UM1 · FY2024 · AI
San Francisco Bay Clinical Trials Unit (CTU)$1,415,682
UM1 · FY2023 · AI
Training in HIV Translational Research$317,725
T32 · FY2023 · AI · contact PI
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa$4,681,869
U01 · FY2022 · AI · contact PI
Strategic antiretroviral therapy and HIV testing for youth in rural Africa$1,904,969
UH3 · FY2022 · HD · contact PI
San Francisco Bay Clinical Trials Unit (CTU)$1,511,389
UM1 · FY2022 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$683,177
R01 · FY2022 · AI · contact PI
Training in HIV Translational Research$87,897
T32 · FY2022 · AI · contact PI
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa$4,804,723
U01 · FY2021 · AI · contact PI
Strategic antiretroviral therapy and HIV testing for youth in rural Africa$1,904,969
UH3 · FY2021 · HD · contact PI
San Francisco Bay Clinical Trials Unit (CTU)$1,347,336
UM1 · FY2021 · AI
Training in HIV Translational Research$158,056
T32 · FY2021 · AI · contact PI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$1
R01 · FY2021 · AI · contact PI
A Multisectoral Strategy to Address Persistent Drivers of the HIV Epidemic in East Africa$4,526,307
U01 · FY2020 · AI · contact PI
San Francisco Bay Clinical Trials Unit$1,934,121
UM1 · FY2020 · AI
Strategic antiretroviral therapy and HIV testing for youth in rural Africa$1,932,719
UH3 · FY2020 · HD · contact PI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$684,762
R01 · FY2020 · AI · contact PI
San Francisco Bay Clinical Trial Unit: Expanding COVID-19 Testing in Heavily Impacted Communities in San Francisco$600,000
UM1 · FY2020 · AI
Training in HIV Translational Research$425,189
T32 · FY2020 · AI · contact PI
San Francisco Bay Clinical Trials Unit$2,634,428
UM1 · FY2019 · AI
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)$1,654,744
UG3 · FY2019 · HD · contact PI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$683,851
R01 · FY2019 · AI · contact PI
Training in HIV Translational Research$379,091
T32 · FY2019 · AI · contact PI
Strategic antiretroviral therapy and HIV testing for youth in rural Africa (SATURN)$1,771,863
UG3 · FY2018 · HD · contact PI
San Francisco Bay Clinical Trials Unit$1,493,196
UM1 · FY2018 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$1,087,552
R01 · FY2018 · AI · contact PI
Training in HIV Translational Research$438,980
T32 · FY2018 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa$1,803,317
P01 · FY2017 · HD · contact PI
San Francisco Bay Clinical Trials Unit$1,490,310
UM1 · FY2017 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden$724,208
R01 · FY2017 · AI · contact PI
The immunologic consequences of prenatal exposure to malaria$437,585
P01 · FY2017 · HD · contact PI
Reducing malaria in HIV-infected pregnant women and children$351,382
P01 · FY2017 · HD · contact PI
Training in HIV Translational Research$300,195
T32 · FY2017 · AI · contact PI
Reducing the burden of malaria in HIV uninfected pregnant women and infants$298,277
P01 · FY2017 · HD · contact PI
Administrative Core$283,754
P01 · FY2017 · HD · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$9,914,336
U01 · FY2016 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa$2,345,862
P01 · FY2016 · HD · contact PI
San Francisco Bay Clinical Trials Unit$1,388,627
UM1 · FY2016 · AI
Reducing malaria in HIV-infected pregnant women and children$519,448
P01 · FY2016 · HD · contact PI
The immunologic consequences of prenatal exposure to malaria$452,725
P01 · FY2016 · HD · contact PI
Reducing the burden of malaria in HIV uninfected pregnant women and infants$443,591
P01 · FY2016 · HD · contact PI
Administrative Core$305,879
P01 · FY2016 · HD · contact PI
Training in HIV Translational Research$134,980
T32 · FY2016 · AI · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$9,737,501
U01 · FY2015 · AI · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$4,859,639
U01 · FY2015 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa$2,331,097
P01 · FY2015 · HD · contact PI
San Francisco Bay Clinical Trials Unit$1,364,094
UM1 · FY2015 · AI
Reducing malaria in HIV-infected pregnant women and children$511,578
P01 · FY2015 · HD · contact PI
The immunologic consequences of prenatal exposure to malaria$466,645
P01 · FY2015 · HD · contact PI
Reducing the burden of malaria in HIV uninfected pregnant women and infants$436,871
P01 · FY2015 · HD · contact PI
Administrative Core$301,244
P01 · FY2015 · HD · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$6,995,851
U01 · FY2014 · AI · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$6,354,317
U01 · FY2014 · AI · contact PI
San Francisco Bay Clinical Trials Unit$4,418,930
UM1 · FY2014 · AI
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa$2,307,055
P01 · FY2014 · HD · contact PI
Reducing malaria in HIV-infected pregnant women and children$505,067
P01 · FY2014 · HD · contact PI
The immunologic consequences of prenatal exposure to malaria$443,370
P01 · FY2014 · HD · contact PI
Reducing the burden of malaria in HIV uninfected pregnant women and infants$435,082
P01 · FY2014 · HD · contact PI
Training in HIV Translational Research$342,098
T32 · FY2014 · AI · contact PI
Administrative Core$299,890
P01 · FY2014 · HD · contact PI
UCSF HIV Clinical Trials Unit$4,128,866
UM1 · FY2013 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve Maternal-Child Health in Africa$1,833,933
P01 · FY2013 · HD · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$887,467
U01 · FY2013 · AI · contact PI
The immunologic consequences of prenatal exposure to malaria$418,219
P01 · FY2013 · HD · contact PI
Training in HIV Translational Research$397,369
T32 · FY2013 · AI · contact PI
Reducing malaria in HIV-infected pregnant women and children$350,403
P01 · FY2013 · HD · contact PI
Reducing the burden of malaria in HIV uninfected pregnant women and infants$347,714
P01 · FY2013 · HD · contact PI
Administrative Core$313,424
P01 · FY2013 · HD · contact PI
UCSF HIV Clinical Trials Unit$6,132,107
UM1 · FY2012 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$2,061,446
P01 · FY2012 · HD · contact PI
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)$963,332
U01 · FY2012 · AI · contact PI
Protease inhibitors to reduce malaria in HIV-infected pregnant women$420,611
P01 · FY2012 · HD · contact PI
Core A. Administrative$320,058
P01 · FY2012 · HD · contact PI
Training in HIV Translational Research$316,123
T32 · FY2012 · AI · contact PI
Therapeutic Strategies for HIV Disease$133,342
K24 · FY2012 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$2,393,553
P01 · FY2011 · HD · contact PI
UCSF HIV Clinical Trials Unit$1,480,225
U01 · FY2011 · AI · contact PI
Protease inhibitors to reduce malaria in HIV-infected pregnant women$542,248
P01 · FY2011 · HD · contact PI
Core A. Administrative$318,471
P01 · FY2011 · HD · contact PI
Training in HIV Translational Research$168,932
T32 · FY2011 · AI · contact PI
Therapeutic Strategies for HIV Disease$133,342
K24 · FY2011 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$2,436,893
P01 · FY2010 · HD · contact PI
UCSF HIV Clinical Trials Unit$1,319,536
U01 · FY2010 · AI · contact PI
Protease inhibitors to reduce malaria in HIV-infected pregnant women$714,052
P01 · FY2010 · HD · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$499,999
P01 · FY2010 · HD · contact PI
PEPFAR - Streamlining care in high CD4, HIV+ adults in Africa$498,108
P30 · FY2010 · AI · contact PI
Core A. Administrative$380,681
P01 · FY2010 · HD · contact PI
Training in HIV Translational Research$187,036
T32 · FY2010 · AI · contact PI
Therapeutic Strategies for HIV Disease$133,342
K24 · FY2010 · AI · contact PI
Protease Inhibitors to Reduce Malaria in HIV-infected Pregnant Women$121,565
P01 · FY2010 · HD · contact PI
Core A: Administrative$64,810
P01 · FY2010 · HD · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$2,394,527
P01 · FY2009 · HD · contact PI
UCSF HIV Clinical Trials Unit$1,018,836
U01 · FY2009 · AI · contact PI
Protease inhibitors to reduce malaria in HIV-infected pregnant women$587,742
P01 · FY2009 · HD · contact PI
Training in HIV Translational Research$363,782
T32 · FY2009 · AI · contact PI
Core A. Administrative$309,847
P01 · FY2009 · HD · contact PI
Therapeutic Strategies for HIV Disease$133,342
K24 · FY2009 · AI · contact PI
Novel Strategies to Prevent Malaria and Improve HIV Outcomes in Africa$2,154,097
P01 · FY2008 · HD · contact PI
UCSF HIV Clinical Trials Unit$1,028,280
U01 · FY2008 · AI · contact PI
Clinical Studies of Interactions Between HIV and Malaria$816,761
U01 · FY2008 · AI · contact PI
Protease inhibitors to reduce malaria in HIV-infected pregnant women$488,297
P01 · FY2008 · HD · contact PI
Core A. Administrative$389,899
P01 · FY2008 · HD · contact PI
Training in HIV Translational Research$280,163
T32 · FY2008 · AI · contact PI
Therapeutic Strategies for HIV Disease$133,342
K24 · FY2008 · AI · contact PI
UCSF HIV Clinical Trials Unit$1,254,022
U01 · FY2007 · AI · contact PI
Clinical Studies of Interactions Between HIV and Malaria$864,699
U01 · FY2007 · AI · contact PI
Training in HIV Translational Research$372,042
T32 · FY2007 · AI · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,290,193
U01 · FY2006 · AI · contact PI
Clinical Studies of Interactions Between HIV and Malaria$919,923
U01 · FY2006 · AI · contact PI
Training in HIV Translational Research$255,098
T32 · FY2006 · AI · contact PI
Therapeutic Strategies for HIV Disease$113,885
K24 · FY2006 · AI · contact PI
ADULT AIDS CLINICAL TRIALS UNIT$1,561,271
U01 · FY2005 · AI
Clinical Studies of Interactions Between HIV and Malaria$945,312
U01 · FY2005 · AI
Training in HIV Translational Research$128,540
T32 · FY2005 · AI
Therapeutic Strategies for HIV Disease$113,885
K24 · FY2005 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,511,271
U01 · FY2004 · AI
Clinical Studies of Interactions Between HIV and Malaria$659,659
U01 · FY2004 · AI
Therapeutic Strategies for HIV Disease$124,745
K24 · FY2004 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,759,926
U01 · FY2003 · AI
Therapeutic Strategies for HIV Disease$135,606
K24 · FY2003 · AI
ADULT AIDS CLINICAL TRIALS UNIT$1,862,162
U01 · FY2002 · AI
Therapeutic Strategies for HIV Disease$111,313
K24 · FY2002 · AI
Therapeutic Strategies for HIV Disease$15,918
K24 · FY2002 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT$1,886,558
U01 · FY2001 · AI
CORE--CLINICAL INVESTIGATION$180,480
P30 · FY2001 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT$1,794,709
U01 · FY2000 · AI
CORE--CLINICAL INVESTIGATION$100,663
P30 · FY2000 · AI